WEE1 Inhibitor: Clinical Development

被引：0
|
作者：
Anthony Kong
Hisham Mehanna
机构：
[1] University of Birmingham,Institute of Head and Neck Studies (InHANSE)
[2] King’s College London,Comprehensive Cancer Centre
来源：
Current Oncology Reports | 2021年 / 23卷
关键词：
WEE1 inhibitor; Adavosertib; AZD1775; TP53 mutation; Biomarker; Clinical trials;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] WEE1 Inhibitor: Clinical Development
    Kong, Anthony
    Mehanna, Hisham
    CURRENT ONCOLOGY REPORTS, 2021, 23 (09)
  • [2] Clinical development of WEE1 inhibitors in gynecological cancers: A systematic review
    Schutte, Tim
    Embaby, Alaa
    Steeghs, Neeltje
    van der Mierden, Stevie
    van Driel, Willemien
    Rijlaarsdam, Martin
    Huitema, Alwin
    Opdam, Frans
    CANCER TREATMENT REVIEWS, 2023, 115
  • [3] Targeting WEE1 Kinase in Gynecological Malignancies
    Zhang, Wenhao
    Li, Qingli
    Yin, Rutie
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2024, 18 : 2449 - 2460
  • [4] WEE1 inhibition in cancer therapy: Mechanisms, synergies, preclinical insights, and clinical trials
    Thangaretnam, Krishnapriya
    Islam, Md Obaidul
    Lv, Jialun
    El-Rifai, Ahmed
    Perloff, Ava
    Soutto, Houda L.
    Peng, Dunfa
    Chen, Zheng
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2025, 211
  • [5] Expression and prognostic value of the WEE1 kinase in gliomas
    Music, Darija
    Dahlrot, Rikke Hedegaard
    Hermansen, Simon Kjaer
    Hjelmborg, Jacob
    de Stricker, Karin
    Hansen, Steinbjorn
    Kristensen, Bjarne Winther
    JOURNAL OF NEURO-ONCOLOGY, 2016, 127 (02) : 381 - 389
  • [6] Expression and prognostic value of the WEE1 kinase in gliomas
    Darija Music
    Rikke Hedegaard Dahlrot
    Simon Kjær Hermansen
    Jacob Hjelmborg
    Karin de Stricker
    Steinbjørn Hansen
    Bjarne Winther Kristensen
    Journal of Neuro-Oncology, 2016, 127 : 381 - 389
  • [7] Effect of food on the pharmacokinetics of the WEE1 inhibitor adavosertib (AZD1775) in patients with advanced solid tumors
    Nagard, Mats
    Ah-See, Mei-Lin
    So, Karen
    Vermunt, Marit
    Thistlethwaite, Fiona
    Labots, Mariette
    Roxburgh, Patricia
    Ravaud, Alain
    Campone, Mario
    Valkenburg-van Iersel, Liselot
    Ottesen, Lone
    Li, Yan
    Mugundu, Ganesh
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2020, 86 (01) : 97 - 108
  • [8] Effect of food on the pharmacokinetics of the WEE1 inhibitor adavosertib (AZD1775) in patients with advanced solid tumors
    Mats Någård
    Mei-Lin Ah-See
    Karen So
    Marit Vermunt
    Fiona Thistlethwaite
    Mariette Labots
    Patricia Roxburgh
    Alain Ravaud
    Mario Campone
    Liselot Valkenburg-van Iersel
    Lone Ottesen
    Yan Li
    Ganesh Mugundu
    Cancer Chemotherapy and Pharmacology, 2020, 86 : 97 - 108
  • [9] A phase Ib study of adavosertib, a selective Wee1 inhibitor, in patients with locally advanced or metastatic solid tumors
    Falchook, Gerald S.
    Sachdev, Jasgit
    Imedio, Esteban Rodrigo
    Kumar, Sanjeev
    Mugundu, Ganesh M.
    Jenkins, Suzanne
    Chmielecki, Juliann
    Jones, Suzanne
    Spigel, David R.
    Johnson, Melissa
    INVESTIGATIONAL NEW DRUGS, 2023, 41 (03) : 493 - 502
  • [10] A phase Ib study of adavosertib, a selective Wee1 inhibitor, in patients with locally advanced or metastatic solid tumors
    Gerald S Falchook
    Jasgit Sachdev
    Esteban Rodrigo Imedio
    Sanjeev Kumar
    Ganesh M Mugundu
    Suzanne Jenkins
    Juliann Chmielecki
    Suzanne Jones
    David R Spigel
    Melissa Johnson
    Investigational New Drugs, 2023, 41 : 493 - 502
12345